GleanMark is free for all of AprilGet free access
EPIVIDIAN, INC. logo

EPIVIDIAN, INC.

9 Marks
Corp.
First Filed:Nov 20, 2006Latest Filed:Oct 30, 2025Address:P.O. Box 141, Libertyville, IL 60048, US

Portfolio Overview

Registered
4(44%)
Pending
2(22%)
Dead
3(33%)

Top Classes

Class 42
Software, IT Services & Scientific Research
6(67%)
Class 35
Advertising, Business Services & Retail
2(22%)
Class 9
Electronics, Software & Scientific Equipment
1(11%)

TTAB Proceedings

No litigation activity

Top Firms

SMITH ANDERSON BLOUNT DORSET...(Oct 2025)
6

Trademark Portfolio

9 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
99471269
99471269
Service Mark
Design
ITU
PENDING
Owner:
Serial:99471269
Filed:Oct 30, 2025
Classes:42
Goods & Services
Class 042: Medical research services
99471268
99471268
Service Mark
Design
ITU
PENDING
Owner:
Serial:99471268
Filed:Oct 30, 2025
Classes:42
Goods & Services
Class 042: Medical research services
ENSEMBLE
ENSEMBLE
Trademark
Word
REGISTERED
Owner:
Serial:86286000
Filed:May 20, 2014
Classes:9
Registration:5418502
Registered:Mar 6, 2018
Goods & Services
Downloadable mobile applications for sending and receiving electronic medical record information, recording medication history, vaccine history and associated symptomatology, sending and receiving electronic laboratory information, sending and receiving insurance billing information, electronic messaging, electronic reminders, electronic adherence responses, scheduling appointments, sending pre-visit checklists, sending and responding to medication questions and other medical questions, sending information on research participation opportunities, sending and responding to medical questionnaires, sending, completing and returning patient-reported-outcomes measurement tools, clinician-reported-outcomes measurement tools and observer-reported-outcomes measurement tools, and recording and transmitting data from wearable or implantable medical devices to facilitate communication between patients and healthcare providers
CHORUS
CHORUS
Service Mark
Word
ABANDONED
Owner:
Serial:86285418
Filed:May 19, 2014
Classes:42
CHORUS
CHORUS
Service Mark
Word
ABANDONED
Owner:
Serial:86038056
Filed:Aug 14, 2013
Classes:42
CHORUS
CHORUS
Service Mark
Word
ABANDONED
Owner:
Serial:85624618
Filed:May 14, 2012
Classes:42
EPIVIDIAN
EPIVIDIAN
Service Mark
Word
REGISTERED
Owner:
Serial:85624595
Filed:May 14, 2012
Classes:35
Registration:4316032
Registered:Apr 9, 2013
Goods & Services
conducting market research via a proprietary database in the medical research field | contract medical research services for others via a proprietary database, namely, conducting pharmacovigilence studies, clinical outcomes assessment, clinical trial protocol feasibility assessment, and clinical trial candidate identification and selection; pharmaceutical information services, namely, clinical data reporting on adverse event reporting systems for pharmaceutical companies; cloud computing featuring software for use by the pharmacovigilance departments of pharmaceutical companies in adverse event management and adverse event signal detection and tracking; providing cloud-based data warehousing and temporary use of non-downloadable software for clinical data reporting and business intelligence for medical records for medical practices and hospital clinics
MAESTRO
MAESTRO
Service Mark
Word
REGISTERED
Owner:
Serial:85624664
Filed:May 14, 2012
Classes:42
Registration:4382154
Registered:Aug 13, 2013
Goods & Services
cloud computing featuring software for use by the pharmacovigilance departments of pharmaceutical companies in adverse event management and adverse event signal detection and tracking
OPERA
OPERA
Service Mark
Word
REGISTERED
Owner:
Serial:77047851
Filed:Nov 20, 2006
Classes:35
Registration:3386020
Registered:Feb 19, 2008
Goods & Services
conducting market research via a proprietary database in the medical research field | contract medical research services for others via a proprietary database, namely, conducting pharmacovigilence studies, clinical outcomes assessment, clinical trial protocol feasibility assessment, and clinical trial patient recruitment